Australian Operations
Include All CSL Behring Country Sites


Normal immunoglobulin (Human) 20% (20 g/100 mL), subcutaneous injection

Health care providers can request educational HIZENTRA materials via our Order Form
HIZENTRA is a preparation of human immunoglobulin for subcutaneous use, which means HIZENTRA is infused just under the first layer of skin. HIZENTRA is prepared from plasma donated in the United States and Europe. 

HIZENTRA is used to treat people who need replacement of antibodies. 

HIZENTRA is available only with a doctor’s prescription.

Who is this information for?
This information is relevant in Australia and is intended for health care professionals or people who have been prescribed this product.

Consumer Medicine Information
The Consumer Medicine Information is a leaflet written for people who have been prescribed HIZENTRA, and contains information about the medicine including:
  • What HIZENTRA is used for
  • How HIZENTRA works
  • How PRIVIGEN is given
  • Side effects
  • Further Information
PDF icon HIZENTRA Consumer Medicine Information (PDF, 3.12MB)
Product Information
Product Information contains information to ensure the safe and effective use of a medicine. This document is approved by the Therapeutic Goods Administration and made available by CSL for you if you are a:
  1. qualified healthcare professional; or
  2. consumer, provided you have read the Consumer Medicine Information for the product; want further information on the product; and agree to consult with your healthcare professional if you have any questions in relation to the Product Information.
PDF icon HIZENTRA Data Sheet (PDF, 0.141MB)

Hizentra® is a Registered trademark of CSL Behring AG